Page last updated: 2024-08-22

trimetazidine and gentiopicroside

trimetazidine has been researched along with gentiopicroside in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ji, N; Sheng, Y; Wang, Y; Zhang, H	1

Other Studies

1 other study(ies) available for trimetazidine and gentiopicroside

Article	Year
Gentiopicroside enhances the protective effect of trimetazidine against myocardial ischemia-reperfusion injury via the AMPK/NLRP3 inflammasome signaling. Journal of biochemical and molecular toxicology, 2023, Volume: 37, Issue:7 Topics: AMP-Activated Protein Kinases; Animals; Inflammasomes; Inflammation; Myocardial Reperfusion Injury; Myocytes, Cardiac; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Trimetazidine	2023

Article

Year

Gentiopicroside enhances the protective effect of trimetazidine against myocardial ischemia-reperfusion injury via the AMPK/NLRP3 inflammasome signaling.

Journal of biochemical and molecular toxicology, 2023, Volume: 37, Issue:7

Topics: AMP-Activated Protein Kinases; Animals; Inflammasomes; Inflammation; Myocardial Reperfusion Injury; Myocytes, Cardiac; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Trimetazidine

2023